Bruce Hammer, PhD, principal investigator at Minneapolis-based CMRR, and his team of researchers grew the bone cells and tested them with a magnetic levitation device that mimics the effects of space microgravity, or weightlessness.
Astronauts lose bone mass in space at a rate faster than individuals suffering from bone diseases like osteoporosis. Dr. Hammer believes studying the process of how this mass is lost could guide the development of new bone disease treatments.
The bone cells are being sent to the ISS to study whether the magnetic levitation device has the same effects on bone cells as space’s low-gravity environment.
“If we can demonstrate that magnetic levitation mimics microgravity, we then have a tool to do space biology on earth,” said Dr. Hammer. “This has implications for developing the next generation of drugs to remediate osteoporosis.”
More articles on supply chain:
Phoenix Children’s Hospital adopts Vizient’s services to improve supply chain
This headband isn’t for fashion— it offers migraine relief
Zimmer Biomet acquires Medtech SA
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
